Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yawei Ding

4PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|Jun 29, 2026
Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

|Dec 10, 2025
Natural killer cell infiltration elicits gender-dependent dichotomous clinical outcomes in urothelial carcinoma.

Lingkai Zhang, Zhaopei Liu, Yawei Ding

|Aug 11, 2025
ARID1A Loss plus CD8+ T-Cell Infiltration Associate with Favorable Clinical Outcomes in Urothelial Carcinoma.

Zhaopei Liu, Lingkai Zhang, Kaifeng Jin

|Apr 07, 2020
Xiao-Ai-Ping Injection Enhances Effect of Paclitaxel to Suppress Breast Cancer Proliferation and Metastasis via Activating Transcription Factor 3.

Junjun Chen, Xiangqi Zhang, Xiao Xiao

Pageof 1

Frequent Collaborators

3 joint publications

Zhaopei Liu

3 joint publications

Lingkai Zhang

3 joint publications

Kaifeng Jin

3 joint publications

Han Zeng

3 joint publications

Xiaohe Su

3 joint publications

Jiaxing Sun

3 joint publications

Yuzhen Wu

3 joint publications

Hailong Liu

3 joint publications

Yu Zhu

3 joint publications

Le Xu

Frequent Collaborators

3 joint publications

Zhaopei Liu

3 joint publications

Lingkai Zhang

3 joint publications

Kaifeng Jin

3 joint publications

Han Zeng